File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction

TitleThe prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
Authors
KeywordsHeart failure with preserved ejection fraction
Tricuspid regurgitation
Predictors
Prognosis
Issue Date2020
PublisherWiley for the Heart Failure Association of the European Society of Cardiology. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2055-5822
Citation
ESC Heart Failure, 2020, v. 7 n. 6, p. 4051-4060 How to Cite?
AbstractAims: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF. Methods and results: From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow-up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all-cause mortality, HF requiring hospitalization and cardiovascular death (log-rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death. Conclusions: The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization.
Persistent Identifierhttp://hdl.handle.net/10722/293815
ISSN
2021 Impact Factor: 3.612
2020 SCImago Journal Rankings: 0.787
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRen, QW-
dc.contributor.authorLi, XL-
dc.contributor.authorFang, J-
dc.contributor.authorChen, Y-
dc.contributor.authorWU, MZ-
dc.contributor.authorYU, YJ-
dc.contributor.authorLiao, SG-
dc.contributor.authorTse, HF-
dc.contributor.authorYiu, KH-
dc.date.accessioned2020-11-23T08:22:11Z-
dc.date.available2020-11-23T08:22:11Z-
dc.date.issued2020-
dc.identifier.citationESC Heart Failure, 2020, v. 7 n. 6, p. 4051-4060-
dc.identifier.issn2055-5822-
dc.identifier.urihttp://hdl.handle.net/10722/293815-
dc.description.abstractAims: Previous studies have demonstrated that moderate/severe tricuspid regurgitation (TR) is associated with adverse outcome in patients with heart failure (HF) with reduced ejection fraction. Little is known about the prevalence and prognostic value of TR in patients of stage B HF and those with stage C HF with preserved ejection fraction (HFpEF). We aimed to investigate the prevalence and prognosis of TR in patients with HFpEF. Methods and results: From 2013 to 2017, 2014 patients with stage B (n = 1341) or C (n = 673) HFpEF were enrolled in the study. Detailed transthoracic echocardiogram was performed, and the severity of TR was graded as no, mild, moderate, and severe. The mean age of the study population was 66.7 ± 14.1 years old, and 46% were men. Mean left ventricular ejection fraction was 62.2 ± 5.5%. The prevalence of moderate/severe TR increased from stage B to C HF (8% to 16%, respectively, P < 0.01). Older age, hyperlipidaemia, atrial fibrillation, left ventricular mass, and right ventricular systolic pressure were independently associated with moderate/severe TR (P < 0.05 for all). With a median follow-up of 3.8 (2.9–4.7) years, 346 patients died and 234 developed HF requiring hospitalization. Kaplan–Meier curve revealed that the presence of moderate/severe TR was associated with all-cause mortality, HF requiring hospitalization and cardiovascular death (log-rank test P < 0.01). Multivariable analysis demonstrated that moderate (hazard ratio = 1.5; 95% confidence interval: 1.1–2.2; P < 0.05) and severe TR (hazard ratio = 2.1; 95% confidence interval: 1.3–3.3; P < 0.01) were independently associated with mortality, HF requiring hospitalization and cardiovascular death. Conclusions: The presence of moderate/severe TR is not uncommon in patients with stage B HF and stage C HFpEF. Importantly, moderate/severe TR was independently associated with mortality and HF requiring hospitalization.-
dc.languageeng-
dc.publisherWiley for the Heart Failure Association of the European Society of Cardiology. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2055-5822-
dc.relation.ispartofESC Heart Failure-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectHeart failure with preserved ejection fraction-
dc.subjectTricuspid regurgitation-
dc.subjectPredictors-
dc.subjectPrognosis-
dc.titleThe prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction-
dc.typeArticle-
dc.identifier.emailTse, HF: hftse@hkucc.hku.hk-
dc.identifier.emailYiu, KH: khkyiu@hku.hk-
dc.identifier.authorityTse, HF=rp00428-
dc.identifier.authorityYiu, KH=rp01490-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1002/ehf2.13014-
dc.identifier.pmid32964655-
dc.identifier.pmcidPMC7754967-
dc.identifier.scopuseid_2-s2.0-85091269838-
dc.identifier.hkuros319713-
dc.identifier.volume7-
dc.identifier.issue6-
dc.identifier.spage4051-
dc.identifier.epage4060-
dc.identifier.isiWOS:000571784400001-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats